• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immunity . Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses

tetano

Editor, Senior Moderator
Immunity


. 2020 Oct 17;S1074-7613(20)30446-5.
doi: 10.1016/j.immuni.2020.10.005. Online ahead of print.
Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses


Jenna J Guthmiller[SUP] 1 [/SUP], Linda Yu-Ling Lan[SUP] 2 [/SUP], Monica L Fern?ndez-Quintero[SUP] 3 [/SUP], Julianna Han[SUP] 4 [/SUP], Henry A Utset[SUP] 1 [/SUP], Dalia J Bitar[SUP] 1 [/SUP], Natalie J Hamel[SUP] 1 [/SUP], Olivia Stovicek[SUP] 1 [/SUP], Lei Li[SUP] 1 [/SUP], Micah Tepora[SUP] 1 [/SUP], Carole Henry[SUP] 1 [/SUP], Karlynn E Neu[SUP] 5 [/SUP], Haley L Dugan[SUP] 2 [/SUP], Marta T Borowska[SUP] 6 [/SUP], Yao-Qing Chen[SUP] 1 [/SUP], Sean T H Liu[SUP] 7 [/SUP], Christopher T Stamper[SUP] 2 [/SUP], Nai-Ying Zheng[SUP] 1 [/SUP], Min Huang[SUP] 1 [/SUP], Anna-Karin E Palm[SUP] 1 [/SUP], Adolfo Garc?a-Sastre[SUP] 8 [/SUP], Raffael Nachbagauer[SUP] 7 [/SUP], Peter Palese[SUP] 7 [/SUP], Lynda Coughlan[SUP] 9 [/SUP], Florian Krammer[SUP] 7 [/SUP], Andrew B Ward[SUP] 4 [/SUP], Klaus R Liedl[SUP] 3 [/SUP], Patrick C Wilson[SUP] 10 [/SUP]



Affiliations
Free article

Abstract

Polyreactivity is the ability of a single antibody to bind to multiple molecularly distinct antigens and is a common feature of antibodies induced upon pathogen exposure. However, little is known about the role of polyreactivity during anti-influenza virus antibody responses. By analyzing more than 500 monoclonal antibodies (mAbs) derived from B cells induced by numerous influenza virus vaccines and infections, we found mAbs targeting conserved neutralizing influenza virus hemagglutinin epitopes were polyreactive. Polyreactive mAbs were preferentially induced by novel viral exposures due to their broad viral binding breadth. Polyreactivity augmented mAb viral binding strength by increasing antibody flexibility, allowing for adaption to imperfectly conserved epitopes. Lastly, we found affinity-matured polyreactive B cells were typically derived from germline polyreactive B cells that were preferentially selected to participate in B cell responses over time. Together, our data reveal that polyreactivity is a beneficial feature of antibodies targeting conserved epitopes.

Keywords: antibody flexibility; broadly neutralizing antibodies; influenza viruses; monoclonal antibodies; polyreactivity.
 
Back
Top Bottom